All News #Library
Quality
FDA shoots down Spectrum`s neutropenia drug, citing manufacturing issues
07 Aug 2021 //
ENDPTS
Rosen Law Firm Reminds Spectrum Pharmaceuticals, Investors- Filed by Firm- SPPI
30 Sep 2016 //
PRNEWSWIRE

Market Place
Sourcing Support